T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume

Lignende værker

• T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume
  af: Ryan C. Lynch, et al.
  Udgivet: (2022-10-01)
• Real-world pharmacovigilance analysis of pralatrexate using the FDA adverse event reporting system database
  af: Wei Yang, et al.
  Udgivet: (2026-04-01)
• Pralatrexate represses the resistance of HCC cells to molecular targeted agents via the miRNA-34a/Notch pathway
  af: Yang Jin, et al.
  Udgivet: (2024-11-01)
• ChatGPT for Pathology Reports in Cutaneous Lymphoma: Accuracy and Readability in Cutaneous Lymphoma
  af: Jennifer Chen, et al.
  Udgivet: (2025-06-01)
• A phase 2 study of frontline pembrolizumab in follicular lymphoma
  af: Carrie Ho, et al.
  Udgivet: (2024-12-01)